Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
410.30
-3.50 (-0.85%)
At close: Feb 11, 2026
Market Cap9.14B +41.5%
Revenue (ttm)631.25M +864.2%
Net Income-246.42M
EPS-11.11
Shares Outn/a
PE Ration/a
Forward PE628.69
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1
Openn/a
Previous Close413.80
Day's Rangen/a
52-Week Range237.50 - 518.20
Betan/a
RSI44.31
Earnings DateFeb 19, 2026

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements